share_log

Karyopharm Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Highbridge Capital Management, LLC(7.2%)

Karyopharm Therapeutics | SC 13G:超过5%持股股东披露文件-Highbridge Capital Management, LLC(7.2%)

美股SEC公告 ·  10/25 21:37
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息